Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors. [electronic resource]
Producer: 20161213Description: 972-9 p. digitalISSN:- 1537-6591
- 2-Naphthylamine
- Adolescent
- Adult
- Anilides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Coinfection -- drug therapy
- Cyclopropanes
- Drug Administration Schedule
- Drug Interactions
- Drug Therapy, Combination -- adverse effects
- Female
- HIV Infections -- complications
- HIV Protease Inhibitors -- administration & dosage
- HIV-1 -- drug effects
- Healthy Volunteers
- Hepacivirus -- drug effects
- Hepatitis C -- complications
- Hepatitis C, Chronic -- complications
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Ritonavir -- administration & dosage
- Sulfonamides -- administration & dosage
- Uracil -- administration & dosage
- Valine
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.